These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 38846953)

  • 1. Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs.
    Chen H; Han Z; Su J; Song X; Ma Q; Lin Y; Ran Z; Li X; Mou R; Wang Y; Li D
    Front Immunol; 2024; 15():1424954. PubMed ID: 38846953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside.
    Jin X; Huang CX; Tian Y
    Clin Exp Med; 2024 Jul; 24(1):146. PubMed ID: 38960924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma.
    Sun L; Cao H; Wang Y; Wang H
    Biol Direct; 2024 Sep; 19(1):80. PubMed ID: 39267124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
    Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
    Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells.
    Qi W; Li Z; Xia L; Dai J; Zhang Q; Wu C; Xu S
    Sci Rep; 2019 Nov; 9(1):16185. PubMed ID: 31700067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.
    Lin X; Yang S
    Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma.
    Chen X; Tang FR; Arfuso F; Cai WQ; Ma Z; Yang J; Sethi G
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31906046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs in ferroptosis and cuproptosis impact on prognosis and treatment in hepatocellular carcinoma.
    Wang K; Yang C; Xie J; Zhang X; Wei T; Yan Z
    Clin Exp Med; 2024 Jun; 24(1):135. PubMed ID: 38907744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA URB1-Antisense RNA 1 (AS1) Suppresses Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving Ferritin Phase Separation.
    Gao Y; Tong M; Wong TL; Ng KY; Xie YN; Wang Z; Yu H; Loh JJ; Li M; Ma S
    ACS Nano; 2023 Nov; 17(22):22240-22258. PubMed ID: 37966480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing.
    Esposti DD; Hernandez-Vargas H; Voegele C; Fernandez-Jimenez N; Forey N; Bancel B; Le Calvez-Kelm F; McKay J; Merle P; Herceg Z
    Oncotarget; 2016 May; 7(22):31862-77. PubMed ID: 26887054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An integrative transcriptomic analysis from Gene Expression Omnibus.
    Xu JH; Chang WH; Fu HW; Yuan T; Chen P
    Mol Med Rep; 2018 May; 17(5):6472-6482. PubMed ID: 29512731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ferroptosis-associated lncRNAs signature predicts the prognosis of hepatocellular carcinoma.
    Wang D; Zhang L; Zhang Y; Zhang Y; Xu S
    Medicine (Baltimore); 2022 Jul; 101(28):e29546. PubMed ID: 35839000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma.
    Sheng J; Lv E; Xia L; Huang W
    Biomed Pharmacother; 2022 Sep; 153():113327. PubMed ID: 35779423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of long noncoding RNAs in hepatocellular carcinoma.
    Huang Z; Zhou JK; Peng Y; He W; Huang C
    Mol Cancer; 2020 Apr; 19(1):77. PubMed ID: 32295598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma.
    Wong LS; Wong CM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of HULC Induces Ferroptosis in Hepatocellular Carcinoma via Targeting of the miR-3200-5p/ATF4 Axis.
    Guan L; Wang F; Wang M; Han S; Cui Z; Xi S; Xu H; Li S
    Oxid Med Cell Longev; 2022; 2022():9613095. PubMed ID: 35615577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis.
    Xu Q; Zhou L; Yang G; Meng F; Wan Y; Wang L; Zhang L
    Cell Biol Int; 2020 Nov; 44(11):2344-2356. PubMed ID: 32808701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.